[Antioxidation mechanism of schizandrin and tanshinonatic acid A and their effects on the protection of cardiotoxic action of adriamycin].
Lin
T J
TJ
D000818:Animals; D002317:Cardiovascular Agents / Q000494:pharmacology*; D034242:Cyclooctanes; D004317:Doxorubicin / Q000009:adverse effects*; D004365:Drugs, Chinese Herbal; D016166:Free Radical Scavengers; D007941:Leukemia P388 / Q000188:drug therapy; D017705:Lignans; D008315:Malondialdehyde / Q000378:metabolism; D008929:Mitochondria, Heart / Q000187:drug effects*; D010616:Phenanthrenes / Q000494:pharmacology*; D011083:Polycyclic Compounds / Q000494:pharmacology*
D002317:Cardiovascular Agents; D034242:Cyclooctanes; D004365:Drugs, Chinese Herbal; D016166:Free Radical Scavengers; D017705:Lignans; D010616:Phenanthrenes; D011083:Polycyclic Compounds; D008315:Malondialdehyde; C024894:tanshinone II A sodium sulfonate; D004317:Doxorubicin; C011105:schizandrin